Title:
TLR5 LIGANDS, THERAPEUTIC METHODS, AND COMPOSITIONS RELATED THERETO
Document Type and Number:
WIPO Patent Application WO/2012/040164
Kind Code:
A3
Abstract:
The disclosure relates to antiviral therapeutic methods and related compositions. In certain embodiments, the disclosure relates to methods of treating or preventing a viral infection by administering a pharmaceutical composition comprising a TLR5 ligand, such as a flagellin, to a subject in need thereof.
More Like This:
Inventors:
GEWIRTZ ANDREW T (US)
ZHANG BENYUE (US)
ZHANG BENYUE (US)
Application Number:
PCT/US2011/052301
Publication Date:
June 21, 2012
Filing Date:
September 20, 2011
Export Citation:
Assignee:
UNIV EMORY (US)
GEWIRTZ ANDREW T (US)
ZHANG BENYUE (US)
GEWIRTZ ANDREW T (US)
ZHANG BENYUE (US)
International Classes:
A61K38/16; A61K38/17; A61K39/12; A61P31/00; A61P31/12
Foreign References:
US20090297552A1 | 2009-12-03 | |||
US20100104516A1 | 2010-04-29 | |||
US20080124361A1 | 2008-05-29 |
Other References:
HUI ZENG ET AL.: "Flagellin/TLR5 responses in epithelia reveal intertwined activation of inflammatory and apototic pathways", AM J PHYSIOL GASTROINTEST LIVER PHYSIOL., vol. 290, 2006, pages G96 - G108
Attorney, Agent or Firm:
MASON, James, C. et al. (Office of Technology Transfer1599 Clifton Road NE, 4th Floo, Atlanta Georgia, US)
Download PDF: